1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors
ePostersLive by SciGen Technologies S.A. All rights reserved.
SOHO 2026 Annual Meeting
September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas
MM - 147
Overall Survival With Anti-BCMA Therapies: Indirect Comparison of Belantamab Mafodotin/Bortezomib/Dexamethasone (BVd) vs Teclistamab/Daratumumab (Tec-Dara) in Relapsed/Refractory Multiple Myeloma
Poster Presenter
Authors
Part of Topic
Multiple Myeloma (MM)
Overall Survival With Anti-BCMA Therapies: Indirect Comparison of Belantamab Mafodotin/Bortezomib/Dexamethasone (BVd) vs Teclistamab/Daratumumab (Tec-Dara) in Relapsed/Refractory Multiple Myeloma